Kelly Blackburn

Insider Reports History

Entity
Individual
Location
C/O Atyr Pharma, Inc., 3545 John Hopkins Court, Suite 250, San Diego, CA
Signature
/s/ William R. Elder, attorney-in-fact for the Reporting Person
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kelly Blackburn:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CervoMed Inc. SVP, Clinical Development Common Stock 13.7K $248K $18.16 Aug 16, 2023 Direct
CervoMed Inc. SVP, Clinical Development Stock Option (Right to Buy) 16K Jan 26, 2024 Direct

Insider Reports Filed by Kelly Blackburn

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRVO CervoMed Inc. Jan 26, 2024 1 $0 4 Jan 26, 2024 SVP, Clinical Development
DFFN CervoMed Inc. Sep 15, 2023 1 $0 4 Sep 15, 2023 VP, Clinical Development
DFFN CervoMed Inc. Aug 16, 2023 0 $0 3 Aug 23, 2023 VP, Clinical Development